Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Maor

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 19, 2001
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver diseaseM Charlton, P Kasparova, S Weston, et al.
Transplantation|August 10, 2000
Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseasesY Maor-Kendler, K P Batts, L J Burgart, et al.
Nephron|January 1, 1985
Hypercalciuric rickets: metabolic studies and pathophysiological considerationsM Tieder, R Samuel, U A Liberman, et al.
The Israel Medical Association Journal : IMAJ|September 9, 2000
Cyclosporin for severe ulcerative colitisT Naftali, B Novis, I Pomeranz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 18, 2006
Hepatitis C at the israeli national hemophilia centerY Maor, D Bashari, G Kenet, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 13, 2006
Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?Y Maor, D Bashari, G Kenet, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 22, 2008
Treatment of hepatitis C in patients with haemophilia - the Israeli National Hemophilia Center experienceY Maor, J M Schapiro, D Bashari, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2007
Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patientsY Maor, P Calès, D Bashari, et al.
Hepatology (Baltimore, Md.)|October 26, 2000
Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantationR Sreekumar, A Gonzalez-Koch, Y Maor-Kendler, et al.
Alimentary Pharmacology & Therapeutics|February 1, 2012
The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBDS Ben-Horin, Y Mazor, H Yanai, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|July 19, 2001
Frequency of nonalcoholic steatohepatitis as a cause of advanced liver diseaseM Charlton, P Kasparova, S Weston, et al.
Transplantation|August 10, 2000
Comparative allograft histology after liver transplantation for cryptogenic cirrhosis, alcohol, hepatitis C, and cholestatic liver diseasesY Maor-Kendler, K P Batts, L J Burgart, et al.
Nephron|January 1, 1985
Hypercalciuric rickets: metabolic studies and pathophysiological considerationsM Tieder, R Samuel, U A Liberman, et al.
The Israel Medical Association Journal : IMAJ|September 9, 2000
Cyclosporin for severe ulcerative colitisT Naftali, B Novis, I Pomeranz, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 18, 2006
Hepatitis C at the israeli national hemophilia centerY Maor, D Bashari, G Kenet, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 13, 2006
Non-invasive biomarkers of liver fibrosis in haemophilia patients with hepatitis C: can you avoid liver biopsy?Y Maor, D Bashari, G Kenet, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 22, 2008
Treatment of hepatitis C in patients with haemophilia - the Israeli National Hemophilia Center experienceY Maor, J M Schapiro, D Bashari, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|November 2, 2007
Improving estimation of liver fibrosis using combination and newer noninvasive biomarker scoring systems in hepatitis C-infected haemophilia patientsY Maor, P Calès, D Bashari, et al.
Hepatology (Baltimore, Md.)|October 26, 2000
Early identification of recipients with progressive histologic recurrence of hepatitis C after liver transplantationR Sreekumar, A Gonzalez-Koch, Y Maor-Kendler, et al.
Alimentary Pharmacology & Therapeutics|February 1, 2012
The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBDS Ben-Horin, Y Mazor, H Yanai, et al.
Pageof 4